| |
|
Healthcare's 'third place--patient-centered healthcare--is life sciences' future business focus, says E&Y
Latest annual Progressions report highlights the shift to healthy behaviors
|
|
US market for pharmaceuticals was $320 billion in 2011, says IMS Institute
Patient office visits, prescription usage continued to decline
|
|
Some good news on drug shortage--finally
Covis Pharmaceuticals' business model is to acquire distribution rights to low-volume drugs
|
|
A scientific approach to site selection
Applying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes
|
|
A conversation with Chris Smith, H. D. Smith
Pharmaceutical Commerce sat down with Chris Smith, president and COO; here's what he had to say.
|
|
McKesson deepens ownership in Canadian retail pharmacy
Buys marketing rights to networks of independent pharmacies for C$920 million
|
|
A Conversation with Meghan Fitzgerald, President, Cardinal Health Specialty Solutions
Cardinal Health, one of the biggest healthcare services companies in the world, has brought together several existing and
recently acquired businesses . . .
|
|
The R&D Decline Is Worse Than Thought, Says Oliver Wyman
White paper points out the drop in pipeline performance; suggests a new direction is necessary . . .
|
|
Life Cycle Management Without Borders
Taking a market-by-market approach to maximizing value after loss of exclusivity . . .
|
|
A conversation with Steve Collis, AmerisourceBergen CEO
Last summer, AmerisourceBergen effected a milestone transfer of leadership- from the company's founding merger in 2001 under R. David Yost, to his successor, Steve Collis. Collis, a 17-year company veteran, had been president of AmerisourceBergen Specialty Group . . .
|
|
|
|
|
